SCHEMBL2369879

SCHEMBL2369879

Cc1cc(C)nc(NC2CC2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM2 P50570 1/20 0.49
PTGS2 P35354 1/20 0.47
MCHR1 Q99705 10/20 0.45
ADRA2A P08913 3/20 0.45
HRH1 P35367 3/20 0.45
ADRA1A P35348 2/20 0.45
HTR2B P41595 2/20 0.45
KDM4E B2RXH2 3/20 0.44
ATM Q13315 2/20 0.44
CNR1 P21554 1/20 0.44
KCNH2 Q12809 1/20 0.44
AURKB Q96GD4 1/20 0.44
HTT P42858 2/20 0.44
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2276674 0.86 PLK4 (0.46) DNM2PTGS2KDM4EATMUSP2
Hydrochloric Acid SCHEMBL3780225 0.85 PLK4 (0.45) DNM2PTGS2KDM4EATMUSP2
SCHEMBL16538391 0.80 WHR1 (0.54) DNM2
SCHEMBL7357755 0.80 MCHR1 (0.43) DNM2PTGS2MCHR1ADRA2AHRH1
SCHEMBL7364277 0.80 MCHR1 (0.40) DNM2PTGS2MCHR1ADRA2AHRH1
SCHEMBL1178837 0.80 MCHR1 (0.45) DNM2PTGS2MCHR1ADRA2AHRH1
SCHEMBL30329781 0.79 DNM2 (0.51) DNM2PTGS2MCHR1ADRA2AHRH1
SCHEMBL26198161 0.79 PLK4 (0.48) KCNH2AURKB
SCHEMBL7362974 0.78 DNM2 (0.53) DNM2PTGS2KDM4EATMHTT
SCHEMBL11474745 0.77 PDE4A (0.48) KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2545042-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Bristol-Myers Squibb Company (US) 2013-01-16 EP disclosed
WO-2011112191-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2011-09-15 WO disclosed